Dr Reddy"s Laboratories plunged on
Friday after it announced weak Q1 numbers. Shares ofthe companyis
trading at Rs 1,605, down Rs 50.6, or 3.06% at the Bombay Stock
Exchange (BSE) on Friday at 11:24 a.m.The company reported Thursday
slightly lower-than-expected growth of 28% in consolidated profit
for the quarter ended June 30, 2012 to Rs 3.36 billion as against
market expectations of Rs 3.53 billion.
Consolidated revenues for the quarter grew 28% over prior year period to Rs 25.4 billion driven by healthy growth in the key markets of North America, Russia and other emerging markets in global generics segment.The scrip has touched an intra-day high of Rs 1,651 and low of Rs 1,598. The total volume of shares traded at the BSE is 23,130.In the earlier session, the shares lost 0.98%, or Rs 16.4, at Rs 1,655.60. Currently, the stock is trading down 11.72% from its 52-week high of Rs 1,818 and above 15.72% over the 52-week low of Rs 1,387.
Share Price Movement Period Pricein Rs Gain/(Loss) in Rs in % 1 Week 1,646.35 9.25 0.56 1 Month 1,589.50 66.10 4.16 3 Months 1,797.05 (141.45) (7.87) 6 Months 1,644.95 10.65 0.65 1 Year 1,543.00 112.60 7.30 Note: Based on previous day closing price.
Post a Comment